Penumbra Total Liabilities 2014-2025 | PEN
Penumbra total liabilities from 2014 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
- Penumbra total liabilities for the quarter ending September 30, 2025 were $0.386B, a 2.89% increase year-over-year.
- Penumbra total liabilities for 2024 were $0.382B, a 1.3% increase from 2023.
- Penumbra total liabilities for 2023 were $0.377B, a 1.43% increase from 2022.
- Penumbra total liabilities for 2022 were $0.372B, a 28.14% increase from 2021.
|
Penumbra Annual Total Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $382 |
| 2023 | $377 |
| 2022 | $372 |
| 2021 | $290 |
| 2020 | $185 |
| 2019 | $180 |
| 2018 | $93 |
| 2017 | $76 |
| 2016 | $42 |
| 2015 | $31 |
| 2014 | $22 |
| 2013 | $23 |
|
Penumbra Quarterly Total Liabilities (Millions of US $) |
|
|---|---|
| 2025-09-30 | $386 |
| 2025-06-30 | $381 |
| 2025-03-31 | $380 |
| 2024-12-31 | $382 |
| 2024-09-30 | $375 |
| 2024-06-30 | $373 |
| 2024-03-31 | $376 |
| 2023-12-31 | $377 |
| 2023-09-30 | $364 |
| 2023-06-30 | $366 |
| 2023-03-31 | $371 |
| 2022-12-31 | $372 |
| 2022-09-30 | $348 |
| 2022-06-30 | $358 |
| 2022-03-31 | $342 |
| 2021-12-31 | $290 |
| 2021-09-30 | $289 |
| 2021-06-30 | $237 |
| 2021-03-31 | $190 |
| 2020-12-31 | $185 |
| 2020-09-30 | $191 |
| 2020-06-30 | $157 |
| 2020-03-31 | $176 |
| 2019-12-31 | $180 |
| 2019-09-30 | $147 |
| 2019-06-30 | $131 |
| 2019-03-31 | $132 |
| 2018-12-31 | $93 |
| 2018-09-30 | $92 |
| 2018-06-30 | $74 |
| 2018-03-31 | $75 |
| 2017-12-31 | $76 |
| 2017-09-30 | $75 |
| 2017-06-30 | $44 |
| 2017-03-31 | $45 |
| 2016-12-31 | $42 |
| 2016-09-30 | $43 |
| 2016-06-30 | $36 |
| 2016-03-31 | $37 |
| 2015-12-31 | $31 |
| 2015-09-30 | $31 |
| 2015-06-30 | $0 |
| 2015-03-31 | $0 |
| 2014-12-31 | |
| 2014-09-30 | $0 |
| 2013-12-31 | $23 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $14.008B | $1.195B |
| Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $239.063B | 28.41 |
| Intuitive Surgical (ISRG) | United States | $187.731B | 73.45 |
| IDEXX Laboratories (IDXX) | United States | $55.613B | 55.23 |
| Edwards Lifesciences (EW) | United States | $49.407B | 33.13 |
| IQVIA Holdings (IQV) | United States | $41.110B | 22.92 |
| Alcon (ALC) | Switzerland | $40.371B | 27.21 |
| Mettler-Toledo (MTD) | United States | $29.477B | 34.49 |
| DexCom (DXCM) | United States | $28.124B | 38.77 |
| STERIS (STE) | Ireland | $25.634B | 26.46 |
| Waters (WAT) | United States | $23.623B | 31.24 |
| Coloplast (CLPBY) | Denmark | $19.267B | 32.88 |
| Hologic (HOLX) | United States | $16.749B | 17.60 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.665B | 0.00 |
| Globus Medical (GMED) | United States | $12.601B | 26.45 |
| Masimo (MASI) | United States | $7.854B | 25.17 |
| Glaukos (GKOS) | United States | $7.131B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $6.163B | 19.58 |
| TransMedics (TMDX) | United States | $4.573B | 54.17 |
| Teleflex (TFX) | United States | $4.550B | 7.25 |
| LivaNova (LIVN) | United Kingdom | $3.455B | 18.66 |
| Veracyte (VCYT) | United States | $3.423B | 39.01 |
| Integer Holdings (ITGR) | United States | $3.048B | 14.31 |
| Alphatec Holdings (ATEC) | United States | $2.530B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.422B | 22.66 |
| Artivion (AORT) | United States | $2.099B | 96.33 |
| UFP Technologies (UFPT) | United States | $2.045B | 27.00 |
| Nihon Kohden (NHNKY) | Japan | $1.953B | 17.05 |
| PROCEPT BioRobotics (PRCT) | United States | $1.729B | 0.00 |
| AxoGen (AXGN) | United States | $1.523B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.406B | 0.00 |
| IRadimed (IRMD) | United States | $1.313B | 62.56 |
| OPKO Health (OPK) | United States | $1.059B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.973B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.950B | 5.14 |
| SiBone (SIBN) | United States | $0.737B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.731B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.725B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.681B | 39.62 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.597B | 11.91 |
| NeuroPace (NPCE) | United States | $0.564B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.550B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.548B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.477B | 13.18 |
| OrthoPediatrics (KIDS) | United States | $0.467B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.436B | 0.00 |
| RxSight (RXST) | United States | $0.409B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.398B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.365B | 60.82 |
| Sight Sciences (SGHT) | United States | $0.337B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Spectral Diagnostics (EDTXF) | Canada | $0.281B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.250B | 0.00 |
| 908 Devices (MASS) | United States | $0.244B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.204B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.197B | 0.00 |
| Inogen (INGN) | United States | $0.173B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.166B | 0.00 |
| CVRx (CVRX) | United States | $0.158B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.156B | 0.00 |
| LENSAR (LNSR) | United States | $0.147B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.138B | 0.00 |
| Neuronetics (STIM) | United States | $0.136B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.136B | 0.00 |
| Solana (HSDT) | United States | $0.125B | 0.00 |
| Hyperfine (HYPR) | United States | $0.124B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.118B | 0.00 |
| Accuray (ARAY) | United States | $0.092B | 0.00 |
| DarioHealth (DRIO) | United States | $0.082B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.081B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.078B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.072B | 0.00 |
| InspireMD (NSPR) | United States | $0.069B | 0.00 |
| Spectral AI (MDAI) | United States | $0.047B | 0.00 |
| Precision Optics (POCI) | United States | $0.039B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.030B | 0.00 | |
| Ekso Bionics Holdings (EKSO) | United States | $0.021B | 0.00 |
| Envoy Medical (COCH) | United States | $0.019B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.016B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.014B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.013B | 0.00 |
| NexGel (NXGL) | United States | $0.013B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.010B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENvue Medical (FEED) | United States | $0.001B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 10.42 |